SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Therapeutic Advances in Respiratory Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sharafkhaneh, A.
Right arrow Articles by Hanania, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharafkhaneh, A.
Right arrow Articles by Hanania, N.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CURCUMIN
Medline Plus Health Information
*Herbal Medicine
*Pneumonia
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Reviews

Review: The potential role of natural agents in treatment of airway inflammation

Amir Sharafkhaneh

MED VA Medical Center, Bldg. 100(111i), 2002 Holcombe Blvd., Houston, TX 77030, amirs{at}bcm.tmc.edu, Baylor College of Medicine, Department of Medicine, Houston, Texas, USA, Michael E. DeBakey VA Medical Center, Houston, Texas, USA

Suryakanta Velamuri

Baylor College of Medicine, Department of Medicine, Houston, Texas, USA, Michael E. DeBakey VA Medical Center, Houston, Texas, USA

Vladimir Badmaev

Sabinsa Corp., New Jersey, NJ, USA, BND Foundation, Staten Island, New York, USA

Charlie Lan

Baylor College of Medicine, Department of Medicine, Houston, Texas, USA, Michael E. DeBakey VA Medical Center, Houston, Texas, USA

Nicola Hanania

Baylor College of Medicine, Department of Medicine, Houston, Texas, USA

Obstructive airway diseases including asthma, chronic obstructive pulmonary disease and cystic fibrosis present with dyspnea and variety of other symptoms. Physiologically, they are characterized by maximal expiratory flow limitation and pathologically, by inflammation of the airways and the lung parenchyma. Inflammation plays a major role in the gradual worsening of the lung function resulting in worsening symptoms. For many years, scientists focused their efforts in identifying various pathways involved in the chronic inflammation present in these diseases. Further, studies are underway to identify various molecular targets in these pathways for the purpose of developing novel therapeutic agents. Natural agents have been used for thousands of years in various cultures for the treatment of several medical conditions and have mostly proven to be safe. Recent in vivo and in vitro studies show potential anti-inflammatory role for some of the existing natural agents. This review provides an overview of the literature related to the anti-inflammatory effects of some of the natural agents which have potential value in the treatment of inflammatory lung diseases.

Key Words: Natural agents • inflammation • COPD • asthma

Therapeutic Advances in Respiratory Disease, Vol. 1, No. 2, 105-120 (2007)
DOI: 10.1177/1753465807086096
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement